Web Results

Amprenavir

en.wikipedia.org/wiki/Amprenavir

Amprenavir is a protease inhibitor used to treat HIV infection. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing ...

Amprenavir: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/amprenavir.html

Easy to read patient leaflet for amprenavir. Includes indications, proper use, special instructions, precautions, and possible side effects.

DrugBank: Amprenavir

www.drugbank.ca/drugs/DB00701

Accession Number, DB00701 (APRD00605). Type, Small Molecule. Groups, Approved. Description, Amprenavir is a protease inhibitor used to treat HIV infection ...

Amprenavir (Agenerase) receives FDA approval. Food and Drug ...

www.ncbi.nlm.nih.gov/pubmed/11366693

AIDS: The Food and Drug Administration (FDA) has approved amprenavir ( Agenerase, formerly known as 141W94 and VX-478) for treatment of HIV. The drug is ...

Agenerase (Amprenavir) Capsules and Oral Solution Drug ... - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/1999/21007lbl.pdf

AGENERASE (amprenavir) in combination with other antiretroviral agents is indicated for ... contains 15 mg of amprenavir in solution and the inactive ingredients ...

Amprenavir (Agenerase)

hivinsite.ucsf.edu/InSite?page=ar-03-05

Jan 25, 2001 ... Approval. Amprenavir was approved by the U.S. Food and Drug Administration ( FDA) in 1999 for use in adults and children with HIV infection.

Agenerase (amprenavir) - CenterWatch

www.centerwatch.com/drug-information/fda-approved-drugs/drug/526/agenerase-amprenavir

Agenerase (amprenavir): For the treatment of HIV-1 infection.. New approved drug details including side effects, uses and general information.

Amprenavir (Agenerase) | aidsinfonet.org | The AIDS InfoNet

www.aidsinfonet.org/fact_sheets/view/445

Manufacture of amprenavir was discontinued in October 2007. It is being replaced by fosamprenavir (see fact sheet 448). Fosamprenavir is a pro-drug of ...

Amprenavir ≥98% (HPLC) | Sigma-Aldrich

www.sigmaaldrich.com/catalog/product/sigma/sml0685?lang=en&region=US

Sigma-Aldrich offers Sigma-SML0685, Amprenavir for your research needs. Find product specific information including CAS, MSDS, protocols and references.

Single-Dose Pharmacokinetics of Amprenavir, a Human ...

aac.asm.org/content/44/4/821.long

ABSTRACT. Amprenavir (141W94) is extensively metabolized by P450 cytochromes, specifically, CYP3A4. Because hepatic insufficiency reduces ...

More Info

amprenavir, Agenerase: Drug Facts, Side Effects and Dosing

www.medicinenet.com

Amprenavir (Agenerase - discontinued brand) is a drug prescribed to treat infections with HIV. Side effects, drug interactions, and pregnancy safety information is ...

amprenavir | C25H35N3O6S - PubChem

pubchem.ncbi.nlm.nih.gov

Amprenavir is a Protease Inhibitor. The mechanism of action of amprenavir is as a HIV Protease Inhibitor, and Cytochrome P450 3A4 Inhibitor, and Cytochrome ...

Agenerase Capsules (Amprenavir Capsules): Side Effects ... - RxList

www.rxlist.com

Jul 16, 2008 ... Learn about Agenerase Capsules (Amprenavir Capsules) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, ...